Track every registration update on the InsiderAlpha IPO tracker.
Updated Jul 16, 2026 · Last SEC filing 2026-06-24
Seaport Therapeutics, Inc. (SPTX) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. 2 Form 8-K material event filings were reported by SPTX in the last 90 days. InsiderAlpha tracks every SPTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0002042347 |
|---|
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-24 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HOMBACH ROBERT J. | Insider | P — Open-market purchase | 13.0K | $18.14 | $236K | SEC | |
| HEALY JAMES | Insider | J — Other acquisition / disposition | 804.4K | — | — | SEC | |
| White Lauren | Chief Financial Officer | J — Other acquisition / disposition | 6.7K | — | — | SEC | |
| Gladstein Lana | General Counsel | J — Other acquisition / disposition | 33.5K | — | — | SEC | |
| Chen Michael Cunyuan | Chief Scientific Officer | J — Other acquisition / disposition | 3.4K | — | — | SEC | |
| Torres Denice | Insider | J — Other acquisition / disposition | 13.4K | — | — | SEC | |
| PAUL STEVEN M | Insider | J — Other acquisition / disposition | 67.0K | — | — | SEC | |
| HEALY JAMES | Insider | J — Other acquisition / disposition | 1.93M | — | — | SEC | |
| ARCH Venture Partners XII, LLC | Insider | J — Other acquisition / disposition | 2.68M | — | — | SEC | |
| ARCH Venture Partners XII, LLC | Insider | P — Open-market purchase | 1.10M | $18.00 | $19.80M | SEC | |
| Loebel Antony | Chief Medical Officer | J — Other acquisition / disposition | 20.1K | — | — | SEC | |
| PureTech Health plc | Insider | J — Other acquisition / disposition | 12.74M | — | — | SEC | |
| PureTech Health plc | Insider | J — Other acquisition / disposition | 2.68M | — | — | SEC | |
| PureTech Health plc | Insider | J — Other acquisition / disposition | 965.3K | — | — | SEC | |
| ARCH Venture Partners XII, LLC | Insider | J — Other acquisition / disposition | 2.51M | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Seaport Therapeutics, Inc. (SPTX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| PureTech Health plc | 6 | — |
| ARCH Venture Partners XII, LLC | 5 | $19.80M |
| HEALY JAMES | 4 | — |
| PAUL STEVEN M | 4 | — |
| Torres Denice | 3 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SPTX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live SPTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.